Drugs / ASPIRIN TRELAMINE
ASPIRIN TRELAMINE
also known as
TF0023 · ASPIRIN TRELAMINE HYDROCHLORIDE · Edan · Edan hydrochloride · TF-0023 HYDROCHLORIDE · X-0023 · X-0023 HYDROCHLORIDE
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05212818 | May 2022 → Feb 2023 | pneumonia | Techfields Inc | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT02785120 | Mar 2017 → Oct 2024 | ischemic stroke | Techfields Inc | Suspended | No outcome recorded Stop: Enrollment |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASPIRIN TRELAMINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314595 ↗ |
| Known as | ASPIRIN TRELAMINE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314595 ↗ |
| Known as | Edan | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314595 ↗ |
| Known as | Edan hydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314595 ↗ |
| Known as | TF-0023 HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314595 ↗ |
| Known as | TF0023 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02785120 ↗ |
| Known as | X-0023 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314595 ↗ |
| Known as | X-0023 HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314595 ↗ |
| Modality | Small molecule | — CHEMBL5314595 ↗ |
| Route | Topical | “as a topical spray” NCT02785120 ↗ |